
Ventyx Biosciences Inc. to Participate in Wells Fargo Healthcare Conference in Boston

Ventyx Biosciences Inc. will participate in the 2025 Wells Fargo Healthcare Conference in Boston on September 5, 2025. Executives will present from 11:00-11:35 AM EDT, and a webcast will be available on the company's website. This announcement was originally published via GlobeNewswire on August 27, 2025.
Ventyx Biosciences Inc., a clinical-stage biopharmaceutical company, will participate in the 2025 Wells Fargo Healthcare Conference in Boston, MA, on Friday, September 5, 2025. Company executives are scheduled to present from 11:00-11:35 AM EDT. A webcast of the presentation will be available on the Ventyx website. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ventyx Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9518743-en) on August 27, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
